Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
52 hedge funds and large institutions have $94.5M invested in Vigil Neuroscience in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 16 closing their positions.
0.38% more ownership
Funds ownership: 69.54% → 69.92% (+0.38%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
10% less capital invested
Capital invested by funds: $105M → $94.5M (-$10.1M)
10% less funds holding
Funds holding: 58 → 52 (-6)
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$3.54M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$871K |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$779K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$534K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$482K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$7.31M |
| 2 |
Goldman Sachs
New York
|
-$1.6M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$309K |
| 4 |
Jane Street
New York
|
-$249K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$231K |
VIGL Hedge Fund Activity: Q3 2024 in Review
52 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q3 2024, worth a combined $94.5M — down 9.6% from $105M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of VIGL and 10 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 13 added.
The largest buyer was Deep Track Capital, adding an estimated $3.54M. The largest seller was Artal Group, exiting entirely with an estimated $7.31M sold.
- 52 institutional investors held Vigil Neuroscience (VIGL) as of Q3 2024, down from 58 in Q2 2024.
- Funds reported $94.5M of Vigil Neuroscience stock for Q3 2024, down 9.6% quarter-over-quarter.
- 10 funds opened new Vigil Neuroscience positions in Q3 2024 and 16 closed out, a net change of -6 holders.
- The largest Vigil Neuroscience buyer in Q3 2024 was Deep Track Capital, an estimated $3.54M added.
- The largest Vigil Neuroscience seller in Q3 2024 was Artal Group, an estimated $7.31M sold.
Based on aggregated 13F filings for Q3 2024.